Pricing Log in Create free account

Better Therapeutics, Inc. (BTTX) vs Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)

Better Therapeutics, Inc. and Scinai Immunotherapeutics Ltd. Sponsored ADR are both Biotechnology companies. Better Therapeutics, Inc. is the larger, with a market value of $850.0K against $640.0K — 1.3× the size. Better Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Scinai Immunotherapeutics Ltd. Sponsored ADR trades at 0.0×. Across the 8 metrics below, Better Therapeutics, Inc. leads on 5 and Scinai Immunotherapeutics Ltd. Sponsored ADR on 3.

Valuation

Metric BTTX SCNI Biotechnology median
P/E n/m 0.01 8.50
P/S n/m n/m 9.71
P/B n/m 0.05 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.28 0.64
EV/Sales n/m n/m 9.21
Earnings yield 0.00% 11,368.55% (33.15%)
Free cash flow yield 0.00% (2,331.48%) (25.50%)

Profitability

Metric BTTX SCNI Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 2,351.81% 0.00% (56.36%)
Return on assets (162.15%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BTTX SCNI Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 45.66% (159.83%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BTTX SCNI Biotechnology median
Debt to equity (1.44) 0.02 0.00
Current ratio 0.57 1.56 4.72
Net debt to EBITDA 0.02 0.25 0.96

Dividend

Metric BTTX SCNI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BTTX SCNI Biotechnology median
Market cap 850.00k 640.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack